Elanco Animal Health Incorporated
ELAN
Classificação em ações
#1886
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Preço da ação
$22.58
Valor de mercado
$11.28B
Variação (1 dia)
-0.51%
Variação (1 ano)
4.44%
País
US
Negociar Elanco Animal Health Incorporated (ELAN)
Categoria
Healthcare
Receita da Elanco Animal Health Incorporated (ELAN)
Receita em Jun 2026 TTM: $5.02B
De acordo com os últimos relatórios financeiros da Elanco Animal Health Incorporated, a receita atual da empresa (TTM) é $5.02B. Em 2023, a empresa obteve uma receita de $4.42B um aumento em relação a a receita do ano 2022, que foi de $4.41B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Elanco Animal Health Incorporated de 2015 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $5.02B | 13.09% |
| 2024 | $4.44B | 0.50% |
| 2023 | $4.42B | 0.14% |
| 2022 | $4.41B | -7.41% |
| 2021 | $4.76B | 45.54% |
| 2020 | $3.27B | 6.59% |
| 2019 | $3.07B | 0.14% |
| 2018 | $3.07B | 6.15% |
| 2017 | $2.89B | -0.84% |
| 2016 | $2.91B | 0.15% |
| 2015 | $2.91B | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 31.71% |
IN
|
